Nuclear Cataract Clinical Trial
Official title:
Phacoemulsification at High IOP and Physiologic IOP: Impact on Anterior and Posterior Segment Physiology
Verified date | January 2024 |
Source | Wolfe Eye Clinic |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this study is to investigate the anterior and posterior structure and functional changes and vascular alterations when performing phacoemulsification at high IOP vs low, more physiological IOP using Centurion® Vision System with Active Sentry® handpiece. These devices are approved by the US Food and Drug Administration (FDA).
Status | Completed |
Enrollment | 27 |
Est. completion date | May 4, 2023 |
Est. primary completion date | May 4, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - No prior ocular surgery including corneal refractive surgery - Bilateral visually significant cataract, similar in density (LOCS III grade 2+), undergoing uncomplicated cataract surgery - Equal dilated pupil size =6mm, no use of pupil expansion devices - Unremarkable systemic health but inclusive of controlled type II diabetes and hypertension with normal OCT angiography at baseline - A1C = 8% on single monotherapy or lifestyle adjustments - To maintain high sensitivity/specificity, patients to fall under OCT normative database: - Axial length 22-26mm - Refractive error between -5.00D to +5.00D - Cylinder = 3.00D - Normal K values <47.00D - Axial eye length cannot vary by more than 0.4 mm in an individual patient - Normal CCT range 540µm ± 50 Exclusion Criteria: - H/o corneal disease or dystrophies - Media opacification for reasons other than cataract - Compromised zonular integrity or stability - Retinal and retinal vascular pathologies, age-related macular degeneration - Glaucoma - Patients with uncontrolled systematic diseases; including hypertension, diabetes, systemic cardiovascular diseases and hematological diseases |
Country | Name | City | State |
---|---|---|---|
United States | Wolfe Eye Clinic | West Des Moines | Iowa |
Lead Sponsor | Collaborator |
---|---|
Matthew Rauen |
United States,
Chen D, Zhu J, Li J, Ding XX, Lu F, Zhao YE. Effect of simulated dynamic intraocular pressure on retinal thickness measured by optical coherence tomography after cataract surgery. Int J Ophthalmol. 2012;5(6):687-93. doi: 10.3980/j.issn.2222-3959.2012.06.0 — View Citation
Li T, Guadie A, Feng L, Fan J, Jiang Z, Liu F. Influence of cataract surgery on macular vascular density in patients with myopia using optical coherence tomography angiography. Exp Ther Med. 2020 Dec;20(6):258. doi: 10.3892/etm.2020.9388. Epub 2020 Oct 27 — View Citation
Liu X, Fang Y, Zhou Y, Wang M, Luo Y. Dynamic changes in retinal vessel density observed by optical coherence tomography angiography after phacoemulsification: active vs gravity fluidics system. Arq Bras Oftalmol. 2022 Apr 8;85(2):205-207. doi: 10.5935/00 — View Citation
Tang Y, Chen X, Zhang X, Tang Q, Liu S, Yao K. Clinical evaluation of corneal changes after phacoemulsification in diabetic and non-diabetic cataract patients, a systematic review and meta-analysis. Sci Rep. 2017 Oct 26;7(1):14128. doi: 10.1038/s41598-017 — View Citation
Vasavada V, Raj SM, Praveen MR, Vasavada AR, Henderson BA, Asnani PK. Real-time dynamic intraocular pressure fluctuations during microcoaxial phacoemulsification using different aspiration flow rates and their impact on early postoperative outcomes: a ran — View Citation
Zeng S, Liang C, He Y, Chen Y, Zhao Q, Dai S, Cheng F, Zhang J, Jiang X. Changes of Subfoveal Choroidal Thickness after Cataract Surgery: A Meta-Analysis. J Ophthalmol. 2018 Nov 12;2018:2501325. doi: 10.1155/2018/2501325. eCollection 2018. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Estimated fluid usage- High IOP Group | Measurement of fluid usage (ml). | Intraoperative | |
Primary | Estimated fluid usage- Low IOP Group | Measurement of fluid usage (ml). | Intraoperative | |
Secondary | Macular Thickness | Macular thickness measured in microns at week 1, month 1, and month 3. Measured by optical coherence tomography (OCT). | post procedure at 1 week, 1 month, and 3 months | |
Secondary | Corneal Thickness | Corneal thickness measured in microns at 1 day, week 1, month 1, and month 3. Measured by pentacam tomography. | post procedure at 1 day, 1 week, 1 month, and 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06325397 -
Less Discomfort and Less Pharmacology. Cataract Surgery at Physiologic Intraocular Pressure (IOP)
|
||
Active, not recruiting |
NCT00825721 -
Dose-Ranging Study of an Ophthalamic Solution in Patients With Loss of Visual Function Due to Age-Related Nuclear Cataract
|
Phase 2 | |
Completed |
NCT04975971 -
A Retrospective Review of DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract Surgery
|
||
Recruiting |
NCT05736042 -
Microinterventional Endocapsular Nuclear Fragmentation Assisted Cataract Surgery
|
N/A |